Physician profile
Robert Owen
NPI 1821212291
$2,990.65
in general payments reported to CMS, 2019-2025
48 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $525 · 2021: $586 · 2022: $846 · 2023: $317 · 2024: $179 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $370.17 | 2020-2025 | Spravato |
| Abbott Laboratories | $251.79 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.36 | 2019-2023 | Ofev |
| Lilly USA, LLC | $149.78 | 2019-2023 | Jardiance, Emgality, Baqsimi |
| Amgen INC. | $133.62 | 2019-2022 | |
| Dynavax Technologies Corporation | $106.72 | 2019-2024 | Heplisav-B |
| Amarin Pharma, INC. | $99.49 | 2020-2021 | |
| Strongbridge US INC. | $91.34 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.76 | 2020-2023 | Trintellix |
| Tris Pharma INC | $84.08 | 2021-2025 | Quillivant |
| Merck Sharp & Dohme LLC | $83.31 | 2019-2022 | |
| Pfizer INC. | $82.53 | 2019-2023 | |
| Glaxosmithkline, LLC. | $82.51 | 2019-2025 | Bexsero |
| Cranial Technologies, INC | $80.08 | 2019-2025 | Doc Band |
| Otsuka America Pharmaceutical, INC. | $78.69 | 2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Owen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.